C4 Therapeutics (CCCC) Net Margin Growth (1y) (2020 - 2026)
Powered by 
Analysis
C4 Therapeutics (CCCC) Net Margin Growth (1y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -392.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,636.00 |
| 10 | C4 Therapeutics | 492.73 Mn | 239.06 Mn | - | 4,670.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4,670.00 |
| Mar 31, 2026 | -4,480.00 |
| Dec 31, 2025 | 48,295.00 |
| Sep 30, 2025 | -12,586.00 |
| Jun 30, 2025 | -25,504.00 |
| Mar 31, 2025 | 56,957.00 |
| Dec 31, 2024 | 39,793.00 |
| Sep 30, 2024 | 8,363.00 |
| Jun 30, 2024 | 120,086.00 |
| Mar 31, 2024 | -799.00 |
| Dec 31, 2023 | 23,716.00 |
| Sep 30, 2023 | 22,898.00 |
| Jun 30, 2023 | -115,413.00 |
| Mar 31, 2023 | -51,213.00 |
| Dec 31, 2022 | -122,492.00 |
| Sep 30, 2022 | -18,278.00 |
| Jun 30, 2022 | 3,657.00 |
| Mar 31, 2022 | -13,072.00 |
| Dec 31, 2021 | 6,038.00 |
| Sep 30, 2021 | 2,981.00 |